Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
PhishPharm - Detail
FDA Home
PhishPharm
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Title:
Absorption, distribution and elimination of oxolinic acid in Atlantic salmon (Salmo salar L.) after various routes of administration.
Authors:
Hustvedt SO, Salte R, Vassvik V
Drug:
Oxolinic acid
Fish species:
Salmon, Atlantic
Date:
1991
t1/2-hr:
42
Sample:
blood, serum
Ave Weight (gm):
1050
Ave Water temp (°C):
9
Water:
Saltwater
Dosage:
10 mg/kg sd
Route:
PO
Comments:
The same fish given the IP dose, 20 mg/kg OA were given 10 mg/kg PO after a clearance period of 6 weeks. Fish were cannulated and given an asprin PO after the surgery, then acclimated 3 weeks. Bioavail=25%. AUC=97 ug/h/ml. T1/2=1.6 alpha, 42.2 beta. C max= 2.5 ug/ml at 3.9h.
Citation:
Aquaculture 95:193-199
Link:
http://dx.doi.org/10.1016/0044-8486(91)90086-M
Genus Species:
Salmo salar
Drug Class:
Antibiotic-Quinolone
t1/2-detail:
1.6 alpha, 42.2 beta, range beta -31.0-54.8 h
Wt gm-detail:
1050+/-95 g
Water temp (°C)-detail:
9+/-0.5 C
Dosage-detail:
10 mg/kg sd
Method:
HPLC/RP, HPLC
Authors-red:
Hustvedt SO, Salte R, Vassvik V
-
-